Smoking-related DNA adducts as potential diagnostic markers of lung cancer: new perspectives; Experimental Oncology; Vol. 37, № 1

Detaylı Bibliyografya
Parent link:Experimental Oncology
Vol. 37, № 1.— 2015.— [P. 5-12]
Müşterek Yazar: Национальный исследовательский Томский политехнический университет (ТПУ) Институт кибернетики (ИК) Кафедра оптимизации систем управления (ОСУ)
Diğer Yazarlar: Grigorjeva E. S. Elena Sergeevna, Kokova D. A. Darjya Alekseevna, Grachev A. N., Cherdyntsev E. S. Evgeny Sergeevich, Buldakov M. A. Mikhail Aleksandrovich, Kzhyshkowska J. G., Cherdyntseva N. V. Nadezhda Viktorovna
Özet:Title screen
In recent years, the new direction such as identification of informative circulating markers reflecting molecular genetic changes in the DNA of tumor cells was actively developed. Smoking-related DNA adducts are very promising research area, since they indicate high pathogenetic importance in the lung carcinogenesis and can be identified in biological samples with high accuracy and reliability using highly sensitive mass spectrometry methods (TOF/TOF, TOF/MS, MS/MS). The appearance of DNA adducts in blood or tissues is the result of the interaction of carcinogenic factors, such as tobacco constituents, and the body reaction which is determined by individual characteristics of metabolic and repair systems. So, DNA adducts may be considered as a cumulative mirror of heterogeneous response of different individuals to smoking carcinogens, which finally could determine the risk for lung cancer. This review is devoted to analysis of the role of DNA adducts in lung carcinogenesis in order to demonstrate their usefulness as cancer associated markers. Currently, there are some serious limitations impeding the widespread use of DNA adducts as cancer biomarkers, due to failure of standardization of mass spectrometry analysis in order to correctly measure the adduct level in each individual. However, it is known that all DNA adducts are immunogenic, their accumulation over some threshold concentration leads to the appearance of long-living autoantibodies. Thus, detection of an informative pattern of autoantibodies against DNA adducts using innovative multiplex ELISA immunoassay may be a promising approach to find lung cancer at an early stage in high-risk groups (smokers, manufacturing workers, urban dwellers).
Dil:İngilizce
Baskı/Yayın Bilgisi: 2015
Konular:
Online Erişim:http://exp-oncology.com.ua/article/7445/smoking-related-dna-adducts-as-potential-diagnostic-markers-of-lung-cancer-new-perspectives
Materyal Türü: Elektronik Kitap Bölümü
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=656565

MARC

LEADER 00000naa0a2200000 4500
001 656565
005 20250404122906.0
035 |a (RuTPU)RU\TPU\network\23006 
035 |a RU\TPU\network\21762 
090 |a 656565 
100 |a 20171120d2015 k||y0rusy50 ba 
101 0 |a eng 
102 |a UA 
135 |a drcn ---uucaa 
181 0 |a i  
182 0 |a b 
200 1 |a Smoking-related DNA adducts as potential diagnostic markers of lung cancer: new perspectives  |f E. S. Grigorjeva [et al.] 
203 |a Text  |c electronic 
300 |a Title screen 
320 |a [References: p. 11-12 (74 tit.)] 
330 |a In recent years, the new direction such as identification of informative circulating markers reflecting molecular genetic changes in the DNA of tumor cells was actively developed. Smoking-related DNA adducts are very promising research area, since they indicate high pathogenetic importance in the lung carcinogenesis and can be identified in biological samples with high accuracy and reliability using highly sensitive mass spectrometry methods (TOF/TOF, TOF/MS, MS/MS). The appearance of DNA adducts in blood or tissues is the result of the interaction of carcinogenic factors, such as tobacco constituents, and the body reaction which is determined by individual characteristics of metabolic and repair systems. So, DNA adducts may be considered as a cumulative mirror of heterogeneous response of different individuals to smoking carcinogens, which finally could determine the risk for lung cancer. This review is devoted to analysis of the role of DNA adducts in lung carcinogenesis in order to demonstrate their usefulness as cancer associated markers. Currently, there are some serious limitations impeding the widespread use of DNA adducts as cancer biomarkers, due to failure of standardization of mass spectrometry analysis in order to correctly measure the adduct level in each individual. However, it is known that all DNA adducts are immunogenic, their accumulation over some threshold concentration leads to the appearance of long-living autoantibodies. Thus, detection of an informative pattern of autoantibodies against DNA adducts using innovative multiplex ELISA immunoassay may be a promising approach to find lung cancer at an early stage in high-risk groups (smokers, manufacturing workers, urban dwellers). 
461 |t Experimental Oncology 
463 |t Vol. 37, № 1  |v [P. 5-12]  |d 2015 
610 1 |a электронный ресурс 
610 1 |a труды учёных ТПУ 
610 1 |a lung cancer 
610 1 |a DNA adducts 
610 1 |a smoking 
610 1 |a ДНК 
610 1 |a курение 
610 1 |a рак легких 
701 1 |a Grigorjeva  |b E. S.  |g Elena Sergeevna 
701 1 |a Kokova  |b D. A.  |g Darjya Alekseevna 
701 1 |a Grachev  |b A. N. 
701 1 |a Cherdyntsev  |b E. S.  |c specialist in the field of informatics and computer technology  |c Associate Professor of Tomsk Polytechnic University, candidate of technical sciences  |f 1953-  |g Evgeny Sergeevich  |3 (RuTPU)RU\TPU\pers\36884  |9 19913 
701 1 |a Buldakov  |b M. A.  |g Mikhail Aleksandrovich 
701 1 |a Kzhyshkowska  |b J. G. 
701 1 |a Cherdyntseva  |b N. V.  |g Nadezhda Viktorovna 
712 0 2 |a Национальный исследовательский Томский политехнический университет (ТПУ)  |b Институт кибернетики (ИК)  |b Кафедра оптимизации систем управления (ОСУ)  |3 (RuTPU)RU\TPU\col\18702 
801 2 |a RU  |b 63413507  |c 20171120  |g RCR 
856 4 |u http://exp-oncology.com.ua/article/7445/smoking-related-dna-adducts-as-potential-diagnostic-markers-of-lung-cancer-new-perspectives 
942 |c CF